Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feraheme for Iron Deficiency in VAD Patients
NCT04080908Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- Jan 2020
- Primary completion
- Oct 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by NYU Langone Health. Started Jan 2020; status: terminated.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04080908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080908.